4//SEC Filing
LALANDE KEVIN M. 4
Accession 0001126234-22-000054
CIK 0001126234other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 5:09 PM ET
Size
5.6 KB
Accession
0001126234-22-000054
Insider Transaction Report
Form 4
LUMOS PHARMA, INC.(LUMO)
LALANDE KEVIN M.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-05+3,431→ 3,431 totalExercise: $8.18Exp: 2032-05-04→ Common Stock (3,431 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant.
Documents
Issuer
LUMOS PHARMA, INC.
CIK 0001126234
Entity typeother
Related Parties
1- filerCIK 0001587800
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 5:09 PM ET
- Size
- 5.6 KB